newsfilter
← Latest News
GlobeNewswire·

Trevena Regains Compliance with Nasdaq Listing and Reaffirms Expected Near-Term Milestones

CHESTERBROOK, Pa., May 30, 2023 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system